Maintenance of identical p53 mutations throughout progression of squamous cell carcinomas of the tongue

European Journal of Cancer. Part B: Oral Oncology

Volumn 30, Issue 5, 1994, Pages 335-337

  Burns, J E ^a   McFarlane, R ^a   Clark, L J ^a,a   Mitchell, R ^b   Robertson, G ^c   Soutar, D ^c   Parkinson, E K ^a  

^a BEATSON INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c CANNIESBURN PLASTIC SURGERY UNIT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CASE REPORT; GENE MUTATION; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TONGUE CARCINOMA; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

CARCINOMA, SQUAMOUS CELL; DISEASE PROGRESSION; GENE DELETION; GENES, P53; HUMAN; LYMPHATIC METASTASIS; POINT MUTATION; POLYMERASE CHAIN REACTION; TONGUE NEOPLASMS;

EID: 0027994585     PISSN: 09641955     EISSN: None     Source Type: Journal    
DOI: 10.1016/0964-1955(94)90035-3     Document Type: Article

References (31)

1. TP53 Tumour suppressor gene—a model for investigating human mutagenesis
2. p53 mutations in human cancers
3. A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinomas
4. Gene mutations and increased levels of p53 protein in human squamous cell carcinomas and their cell lines
5. Mutations in the p53 tumor suppressor gene in human cutaneous squamous cell carcinomas
6. Occurrence of p53 gene deletions and human papilloma virus infection in human head and neck cancer
7. Expression of p53 in premalignant and malignant squamous epithelium
8. High frequency of p53 gene alterations associated with protein overexpression in human squamous cell carcinoma of the larynx
9. p53 overexpression is an early event in the development of human squamous cell carcinoma of the larynx: genetic and prognostic implications
10. Participation of p53 protein in the cellular response to DNA damage
11. A mammalian cell cycle checkpoint pathway utilizing p53 and GAD45 is defective in atasia-telangiectasia
12. Wild type p53 is a cell cycle checkpoint determinant following irradiation
13. Induction of nuclear accumulation of the tumour suppressor protein p53 by DNA-damaging agents
14. ras-Induced hyperplasia occurs with mutation of p53 but activated ras and myc together can induce carcinoma without p53 mutation
15. Discordant p53 gene mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tract
16. Maintenance of p53 alterations throughout breast cancer progression
17. p53 mutations in ovarian cancer: a late event?
18. Alterations of the p53 gene are common and critical events for the maintenance of malignant phenotypes in small lung carcinoma
19. Clonal expansion of p53 mutant cells is associated with brain tumour progression
20. The absence of Harvey ras mutations during development and progression of squamous cell carcinomas of the head and neck
21. A genetic model for colorectal tumorigenesis
22. Suppression of human colorectal carcinoma cell growth by wild-type p53
23. Growth suppression of human breast cancer cells by the introduction of a wild type p53 gene
24. p53 functions as a cell cycle control protein in osteosarcomas
25. Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild type p53
26. Genetic mechanisms of suppression by the human p53 gene
27. Expression of wild type p53 in human A673 cells suppresses tumorigenecity but not growth rate
28. Suppression of acute lymphoblastoid leukemia by the human wild-type p53 gene
29. Tumourigenic keratinocyte lines requiring anchorage and fibroblast support cultured from human squamous cell carcinomas
30. Mutation and protein accumulation during multistage human esophageal carcinogenesis
31. Post translational regulation of the 54K cellular antigen in normal and transformed cells